ClinicalTrials.govpublic full text
Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids
osteopenia, osteoporosis, osteonecrosis, glucocorticoids, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 811831
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.